Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab

被引：0
|
作者：
Jessica R. Allegretti
Edward L. Barnes
Betsey Stevens
Margaret Storm
Ashwin Ananthakrishnan
Vijay Yajnik
Joshua Korzenik
机构：
[1] Brigham and Women’s Hospital,Division of Gastroenterology
[2] Massachusetts General Hospital,Gastroenterology Unit
[3] Harvard Medical School,undefined
来源：
Digestive Diseases and Sciences | 2017年 / 62卷
关键词：
Vedolizumab; Combination therapy; Immunomodulator; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1590 / 1596
页数：6
相关论文
共 50 条
  • [41] Autonomic Dysfunctions in Patients with Inflammatory Bowel Disease in Clinical Remission
    Purnima Sharma
    Govind K. Makharia
    Vineet Ahuja
    Sada Nand Dwivedi
    Kishore Kumar Deepak
    Digestive Diseases and Sciences, 2009, 54 : 853 - 861
  • [42] Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease
    Jalali, Yashar
    Gojdicova, Anna
    Sturdik, Igor
    Toth, Jozef
    Koller, Tomas
    Huorka, Martin
    Jalali, Monika
    Payer, Juraj
    Hlavaty, Tibor
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2023, 124 (07): : 485 - 492
  • [43] Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease: Results of the Swiss Inflammatory Bowel Disease Cohort Study
    Siebert, Uwe
    Wurm, Johannes
    Gothe, Raffaella Matteucci
    Arvandi, Marjan
    Vavricka, Stephan R.
    von Kaenel, Roland
    Begre, Stefan
    Sulz, Michael C.
    Meyenberger, Christa
    Sagmeister, Markus
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 847 - 855
  • [44] Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
    Parikh, Asit
    Fox, Irving
    Leach, Timothy
    Xu, Jing
    Scholz, Catherine
    Patella, Michael
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (08) : 1691 - 1699
  • [45] Cutaneous Morbidity Among Inflammatory Bowel Disease Patients: A Cohort Study
    Vide, Julia
    Osorio, Filipa
    Costa-Silva, Miguel
    Lopes, Sofia
    Azevedo, Filomena
    Dias, Claudia Camila
    Magina, Sofia
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (04) : 442 - 451
  • [46] Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients
    Cicala, Michele
    Gori, Manuele
    Balestrieri, Paola
    Altomare, Annamaria
    Tullio, Alessandro
    Di Cola, Simone
    Dejongh, Sander
    Graziani, Maria Giovanna
    Pagnini, Cristiano
    Carotti, Simone
    Perrone, Giuseppe
    Ribolsi, Mentore
    Fiorani, Marcello
    Guarino, Michele P. L.
    Farre, Ricard
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [47] Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib
    Odah, Tarek
    Karime, Christian
    Desai, Aakash
    Picco, Michael F.
    Kinnucan, Jami A.
    Hashash, Jana G.
    Farraye, Francis A.
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (10) : 3911 - 3919
  • [48] High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)
    Ylisaukko-oja, Tero
    Aaltonen, Jaakko
    Nuutinen, Heikki
    Blomster, Timo
    Jussila, Airi
    Pajala, Markku
    Salminen, Kimmo
    Moilanen, Veikko
    Hakala, Kalle
    Kellokumpu, Mikko
    Toljamo, Kari
    Rautiainen, Henna
    Kuisma, Juha
    Peraaho, Markku
    Molander, Pauliina
    Silvennoinen, Jouni
    Liukkonen, Ville
    Henricson, Hans
    Tillonen, Jyrki
    Esterinen, Mirva
    Nielsen, Christian
    Hirsi, Eija
    Laane, Margus
    Suhonen, Ulla-Maija
    Vihriala, Ilkka
    Makela, Petri
    Puhto, Mika
    Punkkinen, Jari
    Sulonen, Hannu
    Herrala, Sauli
    Jokelainen, Jari
    Tamminen, Klaus
    Sipponen, Taina
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (02) : 158 - 167
  • [49] Combination Therapy Does Not Improve Rate of Clinical or Endoscopic Remission in Patients with Inflammatory Bowel Diseases Treated With Vedolizumab or Ustekinumab
    Hu, Anne
    Kotze, Paulo Gustavo
    Burgevin, Alice
    Tan, Willam
    Jess, Alison
    Li, Pei-Shun
    Kroeker, Karen
    Halloran, Brendan
    Panaccione, Remo
    Peyrin-Biroulet, Laurent
    Ma, Christopher
    Ananthakrishnan, Ashwin N.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (07) : 1366 - +
  • [50] Dietary Profile of Patients with Inflammatory Bowel Disease in Clinical Remission-A Preliminary Study
    Torrinhas, Raquel Susana
    da Rocha, Ilanna Marques Gomes
    Fonseca, Danielle Cristina
    Menezes, Helena
    Prudencio, Ana Paula
    Balmant, Bianca Depieri
    Callado, Leticia
    Damiao, Aderson Omar Mourao Cintra
    Queiroz, Natalia
    Waitzberg, Dan L.
    NUTRIENTS, 2024, 16 (14)
12345